Overview

MDMA-Assisted CBT for OCD (MDMA-CBT4OCD Study)

Status:
Not yet recruiting

Trial end date:
2026-12-01

Target enrollment:

Participant gender:

Summary

The study assesses the safety and preliminary effectiveness of MDMA-assisted cognitive behavioral therapy in participants diagnosed with obsessive-compulsive disorder (OCD).

Phase:

Phase 2

Details

Lead Sponsor:

Carolyn Rodriguez

Treatments:

Methamphetamine